Paul Parkinson is VP at MYRIAD GENETICS INC (MYGN). They have made 1 open-market trade across 1 company since 2021, most recently 2021-03-24.
CIK 0001826133
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYGN | 87,407 | $347K |
Shares reported on the most recent Form 4, priced at the 2021-03-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYGN | SELL | 2021-01-08 | 2021-01-11 | $25.00 | $296K | +4.6% | +10.9% | +7.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.